196 related articles for article (PubMed ID: 24356540)
21. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II activates the RhoA exchange factor Arhgef1 in humans.
Carbone ML; Brégeon J; Devos N; Chadeuf G; Blanchard A; Azizi M; Pacaud P; Jeunemaître X; Loirand G
Hypertension; 2015 Jun; 65(6):1273-8. PubMed ID: 25870189
[TBL] [Abstract][Full Text] [Related]
23. Vascular tone control in humans: insights from studies in Bartter's/Gitelman's syndromes.
Calò LA
Kidney Int; 2006 Mar; 69(6):963-6. PubMed ID: 16528244
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
25. Insulin signaling, glucose metabolism, and the angiotensin II signaling system: studies in Bartter's/Gitelman's syndromes.
Davis PA; Pagnin E; Semplicini A; Avogaro A; Calò LA
Diabetes Care; 2006 Feb; 29(2):469-71. PubMed ID: 16443917
[No Abstract] [Full Text] [Related]
26. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.
Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A
J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.
Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A
Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089
[TBL] [Abstract][Full Text] [Related]
28. Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.
Calò LA; Maiolino G; Pagnin E; Vertolli U; Davis PA
Eur J Clin Invest; 2014 Jun; 44(6):567-72. PubMed ID: 24739026
[TBL] [Abstract][Full Text] [Related]
29. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
Calò LA; Davis PA
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784543
[TBL] [Abstract][Full Text] [Related]
30. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats.
Behuliak M; Vavřínová A; Bencze M; Polgárová K; Ergang P; Kuneš J; Vaněčková I; Zicha J
J Hypertens; 2015 Dec; 33(12):2443-54. PubMed ID: 26418671
[TBL] [Abstract][Full Text] [Related]
31. Bartter's and Gitelman's syndrome.
Seyberth HW; Weber S; Kömhoff M
Curr Opin Pediatr; 2017 Apr; 29(2):179-186. PubMed ID: 27906863
[TBL] [Abstract][Full Text] [Related]
32. Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes.
Davis PA; Mussap M; Pagnin E; Bertipaglia L; Savica V; Semplicini A; Calò LA
Nephrol Dial Transplant; 2006 Jun; 21(6):1697-701. PubMed ID: 16574683
[TBL] [Abstract][Full Text] [Related]
33. Urinary albumin excretion, endothelial dysfunction and cardiovascular risk: study in Bartter's/Gitelman's syndromes and relevance for hypertension.
Calò LA; Davis PA; Palatini P; Semplicini A; Pessina AC
J Hum Hypertens; 2007 Nov; 21(11):904-6. PubMed ID: 17495949
[No Abstract] [Full Text] [Related]
34. [The Gitelman syndrome--a differential diagnosis of Bartter syndrome].
Zimmermann J; Reincke M; Schramm L; Harlos J; Allolio B
Med Klin (Munich); 1994 Dec; 89(12):640-4. PubMed ID: 7869998
[TBL] [Abstract][Full Text] [Related]
35. Bartter's and Gitelman's syndromes: from gene to clinic.
Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D
Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980
[TBL] [Abstract][Full Text] [Related]
36. Does Bartter's syndrome/Gitelman's syndrome provide a clinical model for investigating the association between calcitonin gene-related peptide and angiotensin II-mediated senescence of endothelial progenitor cells?
Tura O; Mills NL; Hadoke PW
J Hypertens; 2010 Oct; 28(10):2170-1; author reply 2171. PubMed ID: 20844373
[No Abstract] [Full Text] [Related]
37. Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats.
Kobayashi N; Nakano S; Mita S; Kobayashi T; Honda T; Tsubokou Y; Matsuoka H
J Pharmacol Exp Ther; 2002 May; 301(2):459-66. PubMed ID: 11961044
[TBL] [Abstract][Full Text] [Related]
38. Chronic renal failure, end-stage renal disease, and peritoneal dialysis in Gitelman's syndrome.
Bonfante L; Davis PA; Spinello M; Antonello A; D'Angelo A; Semplicini A; Calò L
Am J Kidney Dis; 2001 Jul; 38(1):165-8. PubMed ID: 11431196
[TBL] [Abstract][Full Text] [Related]
39. p63RhoGEF regulates auto- and paracrine signaling in cardiac fibroblasts.
Ongherth A; Pasch S; Wuertz CM; Nowak K; Kittana N; Weis CA; Jatho A; Vettel C; Tiburcy M; Toischer K; Hasenfuss G; Zimmermann WH; Wieland T; Lutz S
J Mol Cell Cardiol; 2015 Nov; 88():39-54. PubMed ID: 26392029
[TBL] [Abstract][Full Text] [Related]
40. ROCK (RhoA/Rho Kinase) in Cardiovascular-Renal Pathophysiology: A Review of New Advancements.
Seccia TM; Rigato M; Ravarotto V; Calò LA
J Clin Med; 2020 May; 9(5):. PubMed ID: 32370294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
